Abstract：Objective To study the level of circulating Alarin in obese children and its association with various metabolic parameters. Methods A total of 86 obese children with a body mass index (BMI) above the 95th percentile were enrolled as the obesity group, and 82 healthy children, matched for age and sex, with a BMI below the 85th percentile were enrolled as the healthy control group. According to the presence or absence of insulin resistance (IR), the obesity group was further divided into an IR group with 27 children and a non-IR group with 59 children. Related anthropometric parameters, including body height, body weight, systolic blood pressure (SBP), and diastolic blood pressure (DBP), were measured, and BMI was calculated. Total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), uric acid (UA), fasting insulin (FINS), and fasting blood glucose (FBG) were measured. The area under the receiver operating characteristic curve (AUC) for glucose and insulin, Homeostasis Model Assessment of Insulin Resistance (HOMA-IR), and whole-body insulin sensitivity index (WBISI) were calculated. ELISA was used to measure the level of circulating Alarin. Results The obesity group had a significantly higher level of circulating Alarin than the healthy control group (P < 0.01). The IR group had a significantly higher level of circulating Alarin than the non-IR group (P < 0.01). Circulating Alarin was positively correlated with BMI, TG, FBG, AUC-glucose, AUC-FINS, and HOMA-IR (P < 0.05) and was negatively correlated with WBISI (P < 0.05). The circulating Alarin level had a linear regression relationship with BMI, FBG, and HOMA-IR, among which HOMA-IR had the greatest influence on the circulating Alarin level (P < 0.05). Conclusions There is a significant increase in the circulating Alarin level in obese children, which may be associated with the development of obesity and IR.
LI Man-Qin,LI Jiao-Yang,XIE Li. Level of circulating Alarin in obese children and its association with insulin resistance[J]. CJCP, 2019, 21(10): 983-986.
Weiss R, Dziura J, Burgert TS, et al. Obesity and the metabolic syndrome in children and adolescents[J]. N Engl J Med, 2004, 350(23):2362-2374.
[3]
Tchernof A, Després JP. Pathophysiology of human visceral obesity:an update[J]. Physiol Rev, 2013, 93(1):359-404.
[4]
Yamauchi T, Kadowaki T. Adiponectin receptor as a key player in healthy longevity and obesity-related diseases[J]. Cell Metab, 2013, 17(2):185-196.
[5]
Nigro E, Scudiero O, Ludovica Monaco M, et al. Adiponectin profile and Irisin expression in Italian obese children:association with insulin-resistance[J]. Cytokine, 2017, 94:8-13.
[6]
Thiruvengadam V, Amperayani S, Babu RP, et al. Correlation of childhood obesity and related insulin resistance with leptin and retinol binding protein 4[J]. Indian J Pediatr, 2015, 82(9):799-804.
[7]
Santic R, Schmidhuber SM, Lang R, et al. Alarin is a vasoactive peptide[J]. Proc Natl Acad Sci USA, 2007, 104(24):10217-10222.
[8]
Van Der Kolk N, Madison FN, Mohr M, et al. Alarin stimulates food intake in male rats and LH secretion in castrated male rats[J]. Neuropeptides, 2010, 44(4):333-340.
[9]
Webling KE, Runesson J, Bartfai T, et al. Galanin receptors and ligands[J]. Front Endocrinol (Lausanne), 2012, 3:146.
[10]
Guo L, Fang P, Yu M. Central alarin ameliorated insulin resistance of adipocytes in type 2 diabetic rats[J]. J Endocrinol, 2014, 223(3):217-225.
[11]
Zhang Z, Wu Y, Sheng S, et al. Intracerebroventricular injection of alarin increased glucose uptake in skeletal muscle of diabetic rats[J]. PLoS One, 2015, 10(10):e0139327.
[12]
Fang X, Zhang T, Yang M, et al. High circulating alarin levels are associated with presence of metabolic syndrome[J]. Cell Physiol Biochem, 2018, 51(5):2041-2051.
Mastrangelo A, Martos-Moreno GÁ, García A, et al. Insulin resistance in prepubertal obese children correlates with sexdependent early onset metabolomic alterations[J]. Int J Obes (Lond), 2016, 40(10):1494-1502.
[15]
Conte C, Fabbrini E, Kars M, et al. Multiorgan insulin sensitivity in lean and obese subjects[J]. Diabetes Care, 2012, 35(6):1316-1321.
[16]
Garvey WT, Mechanick JI, Einhorn D. The American Association of Clinical Endocrinologists and the American College of Endocrinology:2014 advanced framework for a new diagnosis of obesity as a chronic disease[J]. Endocr Pract, 2014, 20(9):977-989.
